It underscores the importance of considering HCC in acute abdomen, the limitations of AFP as a sole screening marker (with up to 30% of HCCs being AFP-negative), and the value of a multidisciplinary approach. The gene discussed is AFP; the disease is hepatocellular carcinoma.